Abstract
Tumor heterogeneity and differential drug response in 3D tissue is a major obstacle for survival of cancer patients. Biodynamic 3D imaging provides personalized therapy assessment by testing heterogeneous response of tumor biopsies to anti-cancer drugs.
© 2014 Optical Society of America
PDF Article | Presentation VideoMore Like This
David D. Nolte, John J. Turek, Ran An, Mike Childress, and Daniela Matei
BT4B.3 Biomedical Optics (BIOMED) 2014
David D. Nolte, Zhe Li, Honggu Choi, John Turek, and Shadia Jalal
CTu4B.7 Clinical and Translational Biophotonics (Translational) 2018
David Nolte, Dawith Lim, Zhen Hua, and John Turek
HM1C.2 Digital Holography and Three-Dimensional Imaging (DH) 2023